South Dartmouth (MA): May 9, 2021. \[[PubMed: 25905280](https://pubmed.ncbi.nlm.nih.gov/25905280)\] 31. Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis? Diabetes Care. 2008 Nov;31(11):2081-5. \[[PMC free article: PMC2571050](/pmc/articles/PMC2571050/)\] \[[PubMed: 18694978](https://pubmed.ncbi.nlm.nih.gov/18694978)\] 32. Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004 Sep 01;117(5):291-6. \[[PubMed: 15336577](https://pubmed.ncbi.nlm.nih.gov/15336577)\] 33. Razavi Z, Maher S, Fredmal J. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients. Endocrine. 2018 Aug;61(2):267-274. \[[PubMed: 29797212](https://pubmed.ncbi.nlm.nih.gov/29797212)\] 34. Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism. 2016 Apr;65(4):507-21. \[[PubMed: 26975543](https://pubmed.ncbi.nlm.nih.gov/26975543)\] 35. Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014 Nov;37(11):3124-31. \[[PMC free article: PMC4207202](/pmc/articles/PMC4207202/)\] \[[PubMed: 25342831](https://pubmed.ncbi.nlm.nih.gov/25342831)\] 36. Herpes virus fingerprinting. Lancet. 1979 Feb 03;1(8110):251-2. \[[PubMed: 84904](https://pubmed.ncbi.nlm.nih.gov/84904)\] 37. Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am. 2017 May;101(3):587-606. \[[PMC free article: PMC6535398](/pmc/articles/PMC6535398/)\] \[[PubMed: 28372715](https://pubmed.ncbi.nlm.nih.gov/28372715)\] 38. Duhon B, Attridge RL, Franco-Martinez AC, Maxwell PR, Hughes DW. Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis. Ann Pharmacother. 2013 Jul-Aug;47(7-8):970-5. \[[PubMed: 23737516](https://pubmed.ncbi.nlm.nih.gov/23737516)\] 39. Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, Kaufman F, Quayle K, Roback M, Malley R, Kuppermann N., Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001 Jan 25;344(4):264-9. \[[PubMed: 11172153](https://pubmed.ncbi.nlm.nih.gov/11172153)\] 40. Osuka A, Matsuoka T, Idoguchi K. Is this the worst outcome of metabolic syndrome? Hypophosphatemia and resulting cardiac arrest during the treatment of diabetic ketoacidosis with hypertriglyceridemia. Intern Med. 2009;48(16):1391-5. \[[PubMed: 19687585](https://pubmed.ncbi.nlm.nih.gov/19687585)\] 41. Regmi A, Konstantinov NK, Agaba EI, Rohrscheib M, Dorin RI, Tzamaloukas AH. Respiratory Failure in the Course of Treatment of Diabetic Ketoacidosis. Clin Diabetes. 2014 Jan;32(1):28-31. \[[PMC free article: PMC4521429](/pmc/articles/PMC4521429/)\] \[[PubMed: 26246676](https://pubmed.ncbi.nlm.nih.gov/26246676)\] 42. Abbas Q, Arbab S, Haque AU, Humayun KN. Spectrum of complications of severe DKA in children in pediatric Intensive Care Unit. Pak J Med Sci. 2018 Jan-Feb;34(1):106-109. \[[PMC